{
  "id": "everyday#risk_safety_c459a626",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "Tricyclic antidepressants (TCAs), monamine oxidase sweating, dry mouth, nausea/vomiting, tremor, inhibitors (MAOIs), antipsychotics, vasodilators, and foul body odour, sexual dysfunction. Rarely, alpha or beta adrenergic antagonists make the psychotic reactions, allergic dermatitis, disulfiram-alcohol reaction more serious. Sensitisation peripheral neuritis, or hepatic cell damage can to alcohol continues 6-14 days after taking disulfiram, occur. Severe reactions can lead to confusion, even if in small amounts. cardiovascular collapse, and death. DO NOT use with alcohol, as reactions can be life-threatening or fatal. DO NOT use in women who are pregnant or breastfeeding. CONTRAINDICATED in people with hypertension, heart, liver, or kidney disease, a history of cerebro- vascular accidents, psychosis, impulsivity, or if at risk of suicide. DISORDERS DUE TO SUBSTANCE USE 127 128 SUB 3 DISORDERS DUE TO SUBSTANCE USE Follow-up SUB 3 Follow-up RECOMMENDATIONS ON FREQUENCY OF CONTACT 1 » Harmful use: Follow-up in one month. Follow-up as needed ASSESS FOR IMPROVEMENT thereafter. » Dependence: Follow-up several times per week in the first two weeks, then weekly in the first At every visit, assess: month. Once improving, » decrease frequency to monthly Quantity and frequency of substance use, mental health, physical and as needed thereafter. health, risk and protective factors (e.g. relationships, accommodation, employment, etc.) » Ask about factors that lead to substance use and consequences of substance use RECENT CESSATION OF USE LONG TERM CESSATION OR ONGOING SUBSTANCE USE OR SHIFT TO NON-HARMFUL USE NON-HARMFUL USE » D evelop strategies to reduce harm » C onsider urine testing to confirm abstinence » C onsider occasional urine testing to confirm » T reat health problems » G ive positive feedback to encourage the non-use » D evelop strategies to reduce use maintenance of abstinence/non-harmful use » P ositive feedback » A rrange detoxification or maintenance » T reat other medical problems » S upport factors which reduce the risk of treatment if client agrees » C onsider relapse prevention medications for relapse (such as housing and employment) » C onduct frequent review and outreach alcohol and opioid dependence » T reat other medical problems » C onsider psychosocial therapies to prevent » E ncourage participation in mutual help groups relapse and mutual help groups » L ess frequent review » S upport factors which reduce the risk of relapse such as housing and employment",
  "gloss_vi": "Tricyclic antidepressants (tcas), monamine oxidase sweating, dry mouth, nausea/vomiting, tremor, inhibitors (maois), antipsychotics, vasodilators, and foul body odour, sexual dysfunction. rarely, alpha or beta adrenergic...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "referral",
      "do_not_do"
    ],
    "life_topics": [
      "stress",
      "relationships"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "high"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn Tricyclic antidepressants (TCAs), monamine oxidase sweating, dry mouth, nausea/vomiting, tremor, inhibitors (MAOIs), antipsychotics, vasodilators, and foul body odour, sexual dysfunction. Rarely, alpha or beta adrenergic antagonists make the psychotic reactions, allergic dermatitis, disulfiram-alcohol reaction more serious. Sensitisation peripheral neuritis, or hepatic cell damage can to alcohol continues 6-14 days after taking disulfiram, occur. Severe reactions can lead to confusion, even if in small amounts. cardiovascular collapse, and death. DO NOT use with alcohol, as reactions can be life-threatening or fatal. DO NOT use in women who are pregnant or breastfeeding. CONTRAINDICATED in people with hypertension, heart, liver, or kidney disease, a history of cerebro- vascular accidents, psychosis, impulsivity, or if at risk of suicide. DISORDERS DUE TO SUBSTANCE USE 127 128 SUB 3 DISORDERS DUE TO SUBSTANCE USE Follow-up SUB 3 Follow-up RECOMMENDATIONS ON FREQUENCY OF CONTACT 1 » Harmful use: Follow-up in one month. Follow-up as needed ASSESS FOR IMPROVEMENT thereafter. » Dependence: Follow-up several times per week in the first two weeks, then weekly in the first At every visit, assess: month. Once improving, » decrease frequency to monthly Quantity and frequency of substance use, mental health, physical and as needed thereafter. health, risk and protective factors (e.g. relationships, accommodation, employment, etc.) » Ask about factors that lead to substance use and consequences of substance use RECENT CESSATION OF USE LONG TERM CESSATION OR ONGOING SUBSTANCE USE OR SHIFT TO NON-HARMFUL USE NON-HARMFUL USE » D evelop strategies to reduce harm » C onsider urine testing to confirm abstinence » C onsider occasional urine testing to confirm » T reat health problems » G ive positive feedback to encourage the non-use » D evelop strategies to reduce use maintenance of abstinence/non-harmful use » P ositive feedback » A rrange detoxification or maintenance » T reat other medical problems » S upport factors which reduce the risk of treatment if client agrees » C onsider relapse prevention medications for relapse (such as housing and employment) » C onduct frequent review and outreach alcohol and opioid dependence » T reat other medical problems » C onsider psychosocial therapies to prevent » E ncourage participation in mutual help groups relapse and mutual help groups » L ess frequent review » S upport factors which reduce the risk of relapse such as housing and employment Tricyclic antidepressants (tcas), monamine oxidase sweating, dry mouth, nausea/vomiting, tremor, inhibitors (maois), antipsychotics, vasodilators, and foul body odour, sexual dysfunction. rarely, alpha or beta adrenergic..."
}